Cargando…
Recent progress and perspectives on prostate cancer biomarkers
The application of prostate-specific antigen (PSA) in prostate cancer (PC) screening, diagnosis, and prognosis has improved the clinical management of PC patients. However, the PSA assay has been faced with criticism due to its potential association with over-diagnosis and subsequent overtreatment o...
Autores principales: | Hatakeyama, Shingo, Yoneyama, Tohru, Tobisawa, Yuki, Ohyama, Chikara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Japan
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378754/ https://www.ncbi.nlm.nih.gov/pubmed/27730440 http://dx.doi.org/10.1007/s10147-016-1049-y |
Ejemplares similares
-
Narrative review of urinary glycan biomarkers in prostate cancer
por: Hatakeyama, Shingo, et al.
Publicado: (2021) -
Serum N-glycan profiling is a potential biomarker for castration-resistant prostate cancer
por: Matsumoto, Teppei, et al.
Publicado: (2019) -
I‐branching N‐acetylglucosaminyltransferase regulates prostate cancer invasiveness by enhancing α5β1 integrin signaling
por: Mikami, Jotaro, et al.
Publicado: (2016) -
Wisteria floribunda Agglutinin and Its Reactive-Glycan-Carrying Prostate-Specific Antigen as a Novel Diagnostic and Prognostic Marker of Prostate Cancer
por: Hagiwara, Kazuhisa, et al.
Publicado: (2017) -
Neoadjuvant gemcitabine and carboplatin followed by immediate cystectomy may be associated with a survival benefit in patients with clinical T2 bladder cancer
por: Koie, Takuya, et al.
Publicado: (2014)